{
  "id": "2247620902_2",
  "title": "迪哲医药舒沃哲®获 FDA 加速批准上市，全球首款在美获批的 EGFR exon20ins 肺癌国创新药诞生",
  "content": "<div class=\"rich_media_content js_underline_content autoTypeSetting24psection\" id=\"js_content\">\n <section style=\"text-align: center;margin-left: 8px;margin-right: 8px;\">\n  <a class=\"weapp_image_link js_weapp_entry\" data-miniprogram-appid=\"wx33d4c3735820a33e\" data-miniprogram-applink=\"\" data-miniprogram-imageurl=\"https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vJ9AD3IliaMYHfGS36BCmzgXdafXR0IJsCVVakb1xCPh0IZHqgZiasYzYhJHOypuJCqcYMe5ibWJGpA/640?wx_fmt=png&amp;from=appmsg\" data-miniprogram-nickname=\"Insight医药情报助手\" data-miniprogram-path=\"pages/upgrade/premium/index\" data-miniprogram-servicetype=\"0\" data-miniprogram-type=\"image\" style=\"\">\n   <img class=\"rich_pages wxw-img js_img_placeholder wx_img_placeholder\" data-croporisrc=\"https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vJ9AD3IliaMYHfGS36BCmzgXdafXR0IJsCVVakb1xCPh0IZHqgZiasYzYhJHOypuJCqcYMe5ibWJGpA/0?wx_fmt=png&amp;from=appmsg\" data-cropselx2=\"562\" data-cropsely2=\"106\" data-imgfileid=\"100133277\" data-ratio=\"0.26382978723404255\" data-s=\"300,640\" data-type=\"png\" data-w=\"940\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vJ9AD3IliaMYHfGS36BCmzgXdafXR0IJsCVVakb1xCPh0IZHqgZiasYzYhJHOypuJCqcYMe5ibWJGpA/640?wx_fmt=png&amp;from=appmsg\"/>\n  </a>\n </section>\n <p data-mpa-action-id=\"mclp826hufm\" data-pm-slice=\"0 0 []\" mpa-font-style=\"mclp793ta6a\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   2025 年 7 月 3 日，迪哲医药（股票代码：688192.SH）宣布，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclp825g1bil\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   （ZEGFROVY\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclp80ph1fv\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   ，通用名：舒沃替尼片）的新药上市申请（New Drug Application，NDA），正式获得美国食品药品监督管理局（FDA）批准，用于既往经含铂化疗治疗时或治疗后出现疾病进展，并且经 FDA 批准的试剂盒检测确认，存在表皮生长因子受体（EGFR）20 号外显子插入突变（exon20ins）的局部晚期或转移性非小细胞肺癌（NSCLC）的成人患者。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclp7vpz23pf\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclp7voy6mz\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    通过优先审评程序获得批准上市，成为目前\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     全球首个且唯一\n    </span>\n    在美获批的 EGFR exon20ins NSCLC 国创新药。其在分子设计的源头进行了重大创新，\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     突破难治靶点，是中国首个独立研发在美获批的全球首创新药。\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mclp8twglfe\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclp8tvac5l\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   全球注册临床研究「悟空 1B」（WU-KONG1B）主要研究者、美国哈佛大学医学院附属丹娜法伯癌症研究院 Pasi A. Jänne 教授表示：「作为全球唯一获批的 EGFR exon20ins NSCLC 靶向口服疗法，舒沃替尼的临床数据重塑了这一领域长期缺乏方便有效治疗手段的历史，WU-KONG1B 的数据证实，舒沃替尼展现出显著的疗效优势，且在非亚裔患者群体中得到同样验证。」\n  </span>\n </p>\n <p data-mpa-action-id=\"mclp8yei1bqg\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   迪哲医药创始人、董事长兼首席执行官张小林博士表示：「作为公司的首款在美获批的创新药，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclp8wasz68\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   的加速获批不仅为全球 EGFR 20 号外显子插入突变（exon20ins）非小细胞肺癌（NSCLC）患者带来全新治疗方案，更以中国源头创新迈出『科技创新引领全球』征程上的新跨越。舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclp8ydf212i\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   是目前全球唯一获批治疗 EGFR exon20ins NSCLC 的口服小分子靶向药，具备疗效、安全性及便利性全球同类最佳的潜在优势。这一在美获批的里程碑事件，进一步坚定了迪哲医药致力于以突破性创新疗法填补全球未被满足临床需求的战略决心。」\n  </span>\n </p>\n <p data-mpa-action-id=\"mclp8yei1bqg\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <br/>\n  </span>\n </p>\n <section nodeleaf=\"\" style='margin: 0px 8px 8px;padding: 0px;outline: 0px;max-width: 100%;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;text-align: center;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <img class=\"rich_pages wxw-img js_img_placeholder wx_img_placeholder\" data-imgfileid=\"100000496\" data-ratio=\"0.11296296296296296\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/t741VtpYfug3e9iaEiaLibOnlnnBths3zDCPmYpcYOaWo84WgzOXghseulzZicFlm6hSWjR7FWwsFQfHWE5cmyRrNw/640?wx_fmt=png&amp;tp=webp&amp;wxfrom=10005&amp;wx_lazy=1\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;vertical-align: bottom;box-sizing: border-box !important;overflow-wrap: break-word !important;height: auto !important;visibility: visible !important;width: 1080px !important;\" type=\"block\"/>\n </section>\n <p style='margin: 0px 0px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;text-align: center;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    <span style=\"color: rgb(0, 180, 200);font-weight: bold;\" textstyle=\"\">\n     从中国走向世界，闯出高质量创新国际化道路\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpdi16c8h\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   此次通过优先审评获 FDA 批准，是基于舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpdi011f93\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   在国际多中心注册临床研究「悟空 1B 」（WU-KONG1B）中，针对经治 EGFR exon20ins NSCLC 患者的疗效和安全性数据。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   该项研究成果在 2024 年美国临床肿瘤学会（ASCO）年会以口头报告形式公布，并于近日全文发表于国际顶级杂志《临床肿瘤学期刊》（Journal of Clinical Oncology，影响因子：42.1），研究结果进一步在全球范围内证明了舒沃哲®「强效缩瘤、安全可控、潜在同类最佳」。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpdljn1ko4\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   作为迪哲医药首个源头创新产品，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpdlinnni\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   从国内首例临床研究受试者入组到正式在中国获批上市，用时不到 4 年，这让外界感受到了非一般的「迪哲速度」。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpdntt1wj6\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   2023 年 8 月，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpdnsu18y\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    通过优先审评在中国获批上市，并在获批后的首个医保年度即纳入国家医保目录，成为目前\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     EGFR exon20ins NSCLC 二/后线唯一获批且可医保报销的标准治疗方案，\n    </span>\n    获中国各大权威指南最高等级推荐。\n   </span>\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   中国注册临床研究「悟空 6」（WU-KONG6）主要研究者、「悟空 1B」（WU-KONG1B）主要研究者、北京协和医院王孟昭教授表示：「『悟空 6』（WU-KONG6）研究成果验证了舒沃替尼突破 EGFR exon20ins NSCLC 治疗瓶颈，推动了其在国内获批上市，使得中国患者能率先受益于具有国际领先水平的创新疗法。如今，舒沃替尼在美国成功获批，作为研究者，为来自中国的源头创新成果走向世界，进一步惠及全球患者而深感自豪。」\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpdsdu16ez\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpdscu1vc4\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   的脱颖而出，得益于迪哲医药自成立之初，便坚定不移地坚持放眼全球的源头创新战略。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    迪哲医药成立伊始就锚定全球竞争，\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     所有管线从临床 I 期开始即全球同步开发，均享有完整全球权益。\n    </span>\n    公司已构建七条具备全球差异化竞争力的管线，在多个国家和地区积极推进国际多中心临床研究。\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpdv0p1k11\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   凭借产品的临床优势和全球同步开发策略，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpduzql3g\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   先后获得中、美四项突破性疗法（BTD）的认定，成为全球目前唯一全线治疗 EGFR exon20ins NSCLC 斩获中、美「BTD 大满贯」的药物。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   在 FDA 申报阶段，凭借扎实的科研基础和优异的国际多中心临床数据，舒沃哲®获得了优先审评的资格。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclphws2jqv\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    FDA 的「优先审评资格」主要授予在治疗、诊断或预防某些严重疾病方面取得重大安全性或有效性突破的药物。此前，欧美市场上没有获批治疗 EGFR exon20ins NSCLC 的小分子靶向药，\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     舒沃哲\n    </span>\n   </span>\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclphwr1nc1\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\">\n     <span style=\"font-weight: bold;\" textstyle=\"\">\n      ®\n     </span>\n    </span>\n   </span>\n  </sup>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     是首款在美获批的国创 EGFR-TKI。\n    </span>\n    按照过往的申报数据显示，FDA 的标准审评通常需要 10 个月左右的时间，对于获得优先审评资格的药物，FDA 的目标是在 6 个月内完成审评，从而使得药物能够更快地进入市场，从而更早地惠及患者。\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mclphu98lkm\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclphu81bys\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   的美国获批历程，是中国生物医药产业实力崛起的缩影。它不仅打破了肺癌靶向治疗长期由海外药企主导的格局，真正实现了所在领域中国创新药从「跟跑者」到「引领者」的身份转变，更以「源头创新+自主申报」的形式探索出一条本土 Biotech 高质量创新的国际化道路。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclphu98lkm\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <br/>\n  </span>\n </p>\n <section nodeleaf=\"\" style='margin: 0px 8px 8px;padding: 0px;outline: 0px;max-width: 100%;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;text-align: center;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <img class=\"rich_pages wxw-img js_img_placeholder wx_img_placeholder\" data-imgfileid=\"100000497\" data-ratio=\"0.11296296296296296\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/t741VtpYfug3e9iaEiaLibOnlnnBths3zDCK1MBZZpg7dbTg5nPp0QmSSjloHiaWxFzNccYVx8Xd9S8WX6MtELDpicw/640?wx_fmt=png&amp;tp=webp&amp;wxfrom=10005&amp;wx_lazy=1\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;vertical-align: bottom;box-sizing: border-box !important;overflow-wrap: break-word !important;height: auto !important;visibility: visible !important;width: 1080px !important;\" type=\"block\"/>\n </section>\n <p style='margin: 0px 0px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;text-align: center;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    <span style=\"color: rgb(0, 180, 200);font-weight: bold;\" textstyle=\"\">\n     打造技术壁垒，立足全球竞争\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpgc2t1pv9\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpgc1s1ghz\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    作为\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     全球唯一获批治疗 EGFR exon20ins NSCLC 的口服小分子靶向药，\n    </span>\n    其在美成功获批的关键在于构建了多维度的技术壁垒，使其在竞争激烈的 EGFR exon20ins NSCLC 治疗领域保持领先地位。\n   </span>\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   EGFR exon20ins 突变是非小细胞肺癌难治靶点，因其空间构象特殊、突变亚型繁多、异质性强，导致传统 EGFR TKI 对该靶点基本无效，中位无进展生存期（mPFS）和中位总生存期（mOS）不及 EGFR 敏感突变型晚期 NSCLC 的一半。近年来，全球范围内针对 EGFR exon20ins NSCLC 研发的新药大多以失败告终。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpgfz31iwf\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   迪哲医药首创独特分子结构设计，从源头突破这一难治靶点，并以国际多中心临床试验证实了舒沃替尼在 EGFR exon20ins NSCLC 治疗的突破性价值。与此同时，每日一次的口服给药方式极大的提升了治疗便利性和患者依从性，这在肺癌慢病化管理趋势中具有至关重要的临床价值，使舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpgfy31df5\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   成为临床实践中的理想选择。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpgi4710me\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   随着海外临床的推进，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpgi38p0f\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   有望实现从后线到一线的跃迁，进一步释放其产品的潜力。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclphilu16i9\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   此前，一项于 2023 年欧洲内科肿瘤学会（ESMO）年会公布的汇总分析显示，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclphikt14h1\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   单药一线治疗 EGFR exon20ins NSCLC 经确认的客观缓解率（ORR）达 78.6%，中位无进展生存期（mPFS）为 12.4 个月，强效缩瘤、安全可控，有望进一步重塑该领域一线治疗格局。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclpgrpf22ht\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   2025 年 6 月 19 日，公司宣布，舒沃哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclpgrodr0o\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   对比含铂化疗一线治疗 EGFR exon20ins NSCLC 的全球多中心Ⅲ期临床研究「悟空 28」（WU-KONG28），已于近日顺利完成在全球 16 个国家和地区的全部患者入组。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   当前，迪哲医药围绕着肺癌领域未被满足的医疗需求，已经形成了接力布局。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   针对三代 EGFR TKI 耐药 NSCLC 的现有治疗手段的临床获益有限，DZD6008 是迪哲医药自主研发的一款全新、强效的高选择性 EGFR TKI，在三代 EGFR TKI 和多线治疗失败及脑转移的病人中显示优异的安全性和有效性，有望填补 NSCLC 领域未满足临床需求。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   在血液瘤领域，迪哲医药两款重磅产品在今年上半年召开的美国临床肿瘤学会（ASCO）大会以及国际恶性淋巴瘤会议（ICML）上，斩获三项口头报告。\n  </span>\n </p>\n <p data-mpa-action-id=\"mclphamj22wa\" data-pm-slice=\"0 0 []\" style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   已上市产品高瑞哲\n  </span>\n  <sup leaf=\"\" mpa-font-style=\"mclphalc1kui\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ®\n   </span>\n  </sup>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   是全球首个且唯一针对外周 T 细胞淋巴瘤 (PTCL) 的高选择性 JAK1 抑制剂，打破 PTCL「全球十年无创新药」困局。其独特的「强效抑瘤+抗炎+免疫调节」三重机制，为 PTCL 患者带来显著临床获益。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   另一款是全球首创的非共价 LYN/BTK 双靶点抑制剂：DZD8586。当前，尚无药物能同时应对导致 BTK 抑制剂耐药的两种主要机制。DZD8586 能全面阻断 BCR 信号通路，并完全穿透血脑屏障，针对既往接受过重度治疗的多种 B 细胞非霍奇金淋巴瘤（B-NHL），展现出良好抗肿瘤活性。\n  </span>\n </p>\n <p style='margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgb(51, 51, 51);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   「公司的研发团队在肺癌和血液肿瘤领域有深厚的积累，因此，我们聚焦这两个领域，在我们有差异化优势的领域做全球竞争。」张小林博士表示，「未来，我们将继续深耕未被满足的临床需求，构建高技术壁垒的差异化研发管线，让更多『中国源创』新药惠及全球患者，为中国乃至世界的健康事业贡献『迪哲力量』。」\n  </span>\n </p>\n <p data-pm-slice=\"0 0 []\" style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;color: rgb(178, 178, 178);box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 12px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n     <span leaf=\"\">\n      封面来源：\n      <span style=\"font-weight: normal;\" textstyle=\"\">\n       企业 logo\n      </span>\n     </span>\n    </span>\n   </strong>\n  </span>\n </p>\n <section style=\"margin-left: 8px;margin-right: 8px;\">\n  <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span data-mpa-action-id=\"mclqszvg1324\" data-pm-slice=\"0 0 []\" mpa-font-style=\"mclqszvanky\" style=\"font-size: 12px;\">\n    <span leaf=\"\">\n     <span style=\"color: rgb(178, 178, 178);\" textstyle=\"\">\n      免责声明：\n     </span>\n    </span>\n   </span>\n   <span data-pm-slice=\"0 0 []\" style='color: rgb(178, 178, 178);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 12px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: left;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;caret-color: rgba(0, 0, 0, 0);background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;'>\n    <span leaf=\"\">\n     本文仅作信息分享，不代表 Insight 立场和观点，也不作治疗方案推荐和介绍。如有需求，请咨询和联系正规医疗机构。\n    </span>\n   </span>\n  </strong>\n </section>\n <section style=\"margin-left: 8px;margin-right: 8px;\">\n  <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span data-pm-slice=\"0 0 []\" style='color: rgb(178, 178, 178);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 12px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: left;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;caret-color: rgba(0, 0, 0, 0);background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;'>\n   </span>\n  </strong>\n </section>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;color: rgb(178, 178, 178);box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 12px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n     <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n      <span data-pm-slice='3 2 [\"para\",{\"tagName\":\"section\",\"attributes\":{},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"},\"node\",{\"tagName\":\"strong\",\"attributes\":{\"style\":\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;visibility: visible;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' style='color: rgb(178, 178, 178);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 12px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: left;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;caret-color: rgba(0, 0, 0, 0);background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;'>\n       <strong data-pm-slice=\"0 0 []\" style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2;widows: 2;-webkit-text-stroke-width: 0px;caret-color: rgba(0, 0, 0, 0);white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;color: rgb(178, 178, 178);text-align: justify;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n        <span leaf=\"\" style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n         编辑\n        </span>\n       </strong>\n       <span leaf=\"\" style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2;widows: 2;-webkit-text-stroke-width: 0px;caret-color: rgba(0, 0, 0, 0);background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;color: rgb(178, 178, 178);text-align: justify;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n        ：馨药\n       </span>\n      </span>\n     </strong>\n     <span leaf=\"\">\n      <br/>\n     </span>\n    </span>\n   </strong>\n  </span>\n </p>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;color: rgb(178, 178, 178);box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 12px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n     <span leaf=\"\">\n      PR 稿对接\n     </span>\n    </span>\n   </strong>\n   <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 12px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\">\n     ：微信 insightxb\n    </span>\n   </span>\n  </span>\n </p>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;color: rgb(178, 178, 178);box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <strong style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 12px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n     <span leaf=\"\">\n      投稿\n     </span>\n    </span>\n   </strong>\n   <span style=\"margin-top: 0px;margin-bottom: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 12px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\">\n     ：微信 insightxb；邮箱 insight@dxy.cn\n    </span>\n   </span>\n  </span>\n </p>\n <hr style='margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;background-color: rgb(255, 255, 255);caret-color: rgba(0, 0, 0, 0);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;border-style: solid;border-right-width: 0px;border-bottom-width: 0px;border-left-width: 0px;border-color: rgba(0, 0, 0, 0.1);transform-origin: 0px 0px;transform: scale(1, 0.5);box-sizing: border-box !important;overflow-wrap: break-word !important;'/>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </p>\n <section nodeleaf=\"\" style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", system-ui, -apple-system, system-ui, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <img class=\"rich_pages wxw-img js_img_placeholder wx_img_placeholder\" data-backh=\"35\" data-backw=\"542\" data-before-oversubscription-url=\"https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=png\" data-copyright=\"0\" data-imgfileid=\"502449688\" data-ratio=\"0.06388888888888888\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style='margin: 0px;padding: 0px;outline: 0px;max-width: 100%;vertical-align: bottom;text-align: center;text-indent: 0em;color: rgb(48, 48, 48);font-size: 15px;letter-spacing: 1.5px;widows: 1;font-family: \"Helvetica Neue\", Helvetica, \"Hiragino Sans GB\", \"Microsoft YaHei\", Arial, sans-serif;display: initial;box-sizing: border-box !important;overflow-wrap: break-word !important;height: auto !important;visibility: visible !important;width: 660.984px !important;'/>\n </section>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: center;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgb(48, 48, 48);font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    多样化功能、可溯源数据……\n   </span>\n  </span>\n </p>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: center;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgb(48, 48, 48);font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    Insight 数据库网页版等你体验\n    <img class=\"rich_pages wxw-img js_img_placeholder wx_img_placeholder\" data-imgfileid=\"502449685\" data-ratio=\"1\" data-type=\"png\" data-w=\"64\" src=\"/static/res/logo/https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZapSKkMo4zKejyF1kwocYAdDgiaHuOPBnUFhqWicIL2pJVarklchCnjDxBbdCLIt3FXvuGicJOXnON7A/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;vertical-align: text-bottom;display: inline-block;box-sizing: border-box !important;overflow-wrap: break-word !important;height: auto !important;visibility: visible !important;width: 1080px !important;\"/>\n   </span>\n  </span>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </p>\n <p style='margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;orphans: 2;text-indent: 0em;text-transform: none;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);font-variant-numeric: normal;font-variant-east-asian: normal;color: rgb(34, 34, 34);font-family: \"PingFang SC\", -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 16px;background-color: rgb(255, 255, 255);widows: 1;text-align: center;letter-spacing: 1.5px;line-height: 1.75em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgb(255, 255, 255);background-color: rgb(0, 180, 203);font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span leaf=\"\">\n    点击阅读原文，\n   </span>\n   <strong style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\">\n     立刻\n    </span>\n   </strong>\n   <strong style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\">\n     解锁\n    </span>\n   </strong>\n   <span leaf=\"\">\n    ！\n   </span>\n  </span>\n  <span leaf=\"\">\n   <img class=\"rich_pages wxw-img js_img_placeholder wx_img_placeholder\" data-copyright=\"0\" data-imgfileid=\"502449686\" data-ratio=\"0.125\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZsSTG4CvxVOsgyYs36Biav0Peywg39IiboTfliboldm2SDTmYnbfopNhFNPQ8XXlfF9GeoNAGLRM3KQ/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;vertical-align: bottom;text-indent: 0em;display: initial;box-sizing: border-box !important;overflow-wrap: break-word !important;height: auto !important;visibility: visible !important;width: 660.984px !important;\"/>\n   <img class=\"rich_pages wxw-img js_darkmode__57 js_img_placeholder wx_img_placeholder\" data-backh=\"120\" data-backw=\"562\" data-copyright=\"0\" data-imgfileid=\"502449687\" data-ratio=\"0.21388888888888888\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZsSTG4CvxVOsgyYs36Biav0IPufv0rfuZIZObNwZ2xqviazG11ia1vlX9hQn3UEf4ExlMrllwicluZ4A/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style=\"margin: 0px;padding: 0px;outline: 0px;max-width: 100%;vertical-align: bottom;text-align: start;color: rgb(51, 51, 51);letter-spacing: 1px;box-sizing: border-box !important;overflow-wrap: break-word !important;height: auto !important;width: 561.984px !important;visibility: visible !important;\"/>\n  </span>\n </p>\n <p style=\"display: none;\">\n  <mp-style-type data-value=\"3\">\n  </mp-style-type>\n </p>\n</div>\n",
  "publish_time": 1751500989,
  "mp_id": "MP_WXS_3975077766",
  "pic_url": "https://mmbiz.qlogo.cn/mmbiz_jpg/lVFg8Ny0F8uRl3VfZnIw2xo5QtPTs5LRlJeHvLJK4ec2rhRkicCsbKDPZicB5WTS9rp1Wib0nJCKo7W3ACwQopsyw/0?wx_fmt=jpeg",
  "mp_name": "Insight数据库"
}